Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04646070
Other study ID # Reduction mammaplasty
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 20, 2020
Est. completion date January 20, 2021

Study information

Verified date November 2020
Source Kafrelsheikh University
Contact Rami Ali Abdelkareem Eleiba, Master
Phone +2 01028835799
Email Ramieleiba@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A comparison study between superomedial and Inferior pedicle techniques in wise pattern reduction mammaplasty


Description:

To compare complications of both techniques in wise pattern reduction mammaplasty and to correlate between complications and patient mediated factors


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date January 20, 2021
Est. primary completion date January 20, 2021
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Exclusion Criteria: - previous extensive breast surgery Breast cancer

Study Design


Related Conditions & MeSH terms

  • To Compare Complications of Both Techniques in Wise Pattern Reduction Mammaplasty and to Correlate Between Complications and Patient Mediated Factors

Intervention

Procedure:
Reduction mammaplasty
Breast reduction surgery

Locations

Country Name City State
Egypt Kafr Elsheikh University Hospital Kafr Ash Shaykh

Sponsors (1)

Lead Sponsor Collaborator
Kafrelsheikh University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary To compare complications of both techniques including nipple areola complex necrosis Complications include NAC necrosis and other minor complications including wound dehiscence and seroma or hematoma 30 days postoperative
Secondary To correlate between complications and patient mediated factors Patient mediated factors including age, BMI, preoperative hb, suprasternal notch to nipple distance 30 days postoperative